Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation
Aim. To study the changes of the levels of cardiac biomarkers (N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (hsTnI)) in patients with newly diagnosed multiple myeloma (MM) during programmatic treatment with bortezomib (VCd regimen).Material and methods. This p...
Main Authors: | E. V. Fomina, S. A. Kardovskaya, D. A. Budanova, P. A. Markin, S. A. Appolonova, A. S. Lishuta, Yu. N. Belenkov, I. S. Ilgisonis |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2023-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2955 |
Similar Items
-
Pseudohyperphosphatemia in a patient with relapsed multiple myeloma after bone marrow transplantation: A case report
by: Kittrawee Kritmetapak, et al.
Published: (2019-07-01) -
Myelomatous Pleural Effusion in a Relapse Plasmablastic Myeloma
by: Prachi Tripathi, et al.
Published: (2021-06-01) -
Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
by: Lena Hinrichs, et al.
Published: (2020-05-01) -
Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01) -
Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
by: A. A. Avagimyan
Published: (2022-06-01)